Merck (known as MSD outside the US and Canada) has announced that its investigational 9-valent HPV vaccine prevented

Swiss pharma company Roche is to pay up to 500 million in Swiss francs (CHF) in a new

The US Food and Drug Administration has approved Genentech’s chronic lymphocytic leukemia drug Gazyva. It is the first

Leading diabetes company, Novo Nordisk, has increased its operating profit by 10% in the first nine months of

AstraZeneca’s third quarter of 2013 saw a 4% decline in revenue due to the ongoing impact from key

The Bayer Group continues its positive business momentum according to its third quarter financial results. Sales were level

The world’s largest generic drugmaker, Teva Pharmaceutical Industries, has announced that Dr Jeremy Levin is to step down

For French drugmaker Sanofi, the third quarter of 2013 marked the end of its patent cliff period and

Worldwide pharmaceutical sales for Merck & Co declined by 4% to US $9.5 billion in the third quarter